InflaRx N.V.

InflaRx N.V.'s next confirmed earnings release is scheduled for November 6, 2026.

As of June 30, 2026, InflaRx N.V. has 147.37M shares outstanding.

As of June 30, 2026, InflaRx N.V. maintains a current ratio of 8.22, meaning it holds 8.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.57, indicating moderate leverage, while an interest coverage ratio of -591.44 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, InflaRx N.V. posted a negative return on equity (ROE) of -38.52, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -32.57, reflecting losses generated across the asset base. The company generates approximately -2,998.11 in revenue per employee across its workforce of 67.25, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, InflaRx N.V. recorded 245,157.31 in income tax expense. The company reported a pretax loss of -780.14M and -781.35M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on August 19, 2026, InflaRx N.V.'s stock has gained approximately 41.47% over the past 52 weeks.

Over the twelve months ended June 30, 2026, InflaRx N.V. generated -201,623.02 in revenue and converted that into -781.35M in net income, yielding earnings per share of -9.46. EBITDA reached -723.09M, while operating income came in at -729.46M.

As of June 30, 2026, InflaRx N.V. holds 3.16B in cash and equivalents against 16.63M in total debt, resulting in a net debt position of -2.93B. Total book value stands at 2.92B, with working capital of 2.90B providing operational flexibility.

InflaRx N.V. produced -473.26M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -2.71M in capital expenditures, free cash flow totaled -475.98M - equivalent to -5.77 per share.

Over the twelve months ended June 30, 2026, InflaRx N.V. posted a gross margin of 48,201.61, reflecting its pricing power and cost economics. The operating margin of 361,793.12 and net profit margin of 387,532.08 provide insight into operational efficiency.